SUB1 and cholangiocarcinoma: PC4 was highly expressed in nine malignancies, including cholangiocarcinoma, esophageal cancer, colon cancer, and HCC, while it was expressed at low levels in kidney chromophobe, kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma, and thyroid cancer (Fig. 1A).